Aprea Therapeutics Announces Closing of $5.5 Million Underwritten Public Offering of Common StockGlobeNewsWire • 02/27/23
Aprea Therapeutics Announces Pricing of $5.5 Million Underwritten Public Offering of Common StockGlobeNewsWire • 02/23/23
Aprea Therapeutics to Participate in 6th Annual DNA Damage and Response (DDR) Inhibitors SummitGlobeNewsWire • 01/19/23
Karolinska Development's portfolio company Aprea Therapeutics doses the first patient in a clinical phase 1/2a study of ATRN-119GlobeNewsWire • 01/12/23
Aprea Therapeutics Reports Third Quarter 2022 Financial Results and Provides Update on Business OperationsGlobeNewsWire • 11/09/22
Aprea Therapeutics Announces Poster Presentation at the 2022 Rivkin Center and American Association for Cancer (AACR) Virtual Ovarian Cancer Research Seminar SeriesGlobeNewsWire • 09/22/22
Aprea Therapeutics Reports Second Quarter 2022 Financial Results and Provides Update on Business OperationsGlobeNewsWire • 08/11/22
Karolinska Development's portfolio company Aprea Therapeutics acquires Atrin PharmaceuticalsGlobeNewsWire • 05/17/22
Aprea Therapeutics Announces Acquisition of Atrin Pharmaceuticals Inc. and Reports First Quarter 2022 Financial ResultsGlobeNewsWire • 05/16/22
Aprea Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Update on Business OperationsGlobeNewsWire • 03/15/22
Aprea Therapeutics, Inc. (APRE) Loses 21.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks Investment Research • 01/14/22
Aprea Therapeutics Presents Primary Analysis from Phase 2 Trial of Eprenetapopt + Azacitidine for Post-Transplant Maintenance Therapy in TP53 Mutant MDS and AML at the 2021 American Society of Hematology (ASH) Annual MeetingGlobeNewsWire • 12/13/21
Aprea Therapeutics Reports Third Quarter 2021 Financial Results and Provides Update on Business OperationsGlobeNewsWire • 11/08/21
Aprea Therapeutics to Present Data from Clinical Trials Evaluating Eprenetapopt at 63rd American Society of Hematology Annual MeetingGlobeNewsWire • 11/04/21